Clinical Trial Update: Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis [Phase 3]

View source ↗

Summary

A Phase 3 non-inferiority trial comparing dapaconazole 2% cream with ketoconazole 2% cream for treatment of tinea pedis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Dapaconazole Cream 2% (dapaconazole)
• Ketoconazole cream, 2% (ketoconazole)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Tinea Pedis | Phase 3 | Status: WITHDRAWN